1-3 of 3
John Ostresh
Close
Sort by
Journal Articles

Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis

Arnon P. Kater, Frank Dicker, Massimo Mangiola, Kate Welsh, Richard Houghten, John Ostresh, Adel Nefzi, John C. Reed, Clemencia Pinilla, Thomas J. Kipps
Journal: Blood
Blood (2005) 106 (5): 1742–1748.
https://doi.org/10.1182/blood-2005-02-0695
Published: 2005
Journal Articles

Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells

Bing Z. Carter, Marcela Gronda, Zhiliang Wang, Kate Welsh, Clemencia Pinilla, Michael Andreeff, Wendy D. Schober, Adel Nefzi, Gregory R. Pond, Imtiaz A. Mawji, Richard A. Houghten, John Ostresh, Joseph Brandwein, Mark D. Minden, Andre C. Schuh, Richard A. Wells, Hans Messner, Kathy Chun, John C. Reed, Aaron D. Schimmer
Journal: Blood
Blood (2005) 105 (10): 4043–4050.
https://doi.org/10.1182/blood-2004-08-3168
Published: 2005
Journal Articles

Inhibition of XIAP Renders Newly CD40-Activated Chronic Lymphocytic Leukemia Cells Sensitive to Fas (CD95) Mediated Apoptosis.

Arnon P. Kater, MD, Frank Dicker, PhD, Massimo Mangiola, PhD, Kate Welsh, John Ostresh, PhD, Richard Houghten, PhD, John C. Reed, MD, PhD, Thomas J. Kipps, MD, PhD, Clemencia Pinilla, PhD
Journal: Blood
Blood (2004) 104 (11): 3474.
https://doi.org/10.1182/blood.V104.11.3474.3474
Published: 2004